MBI.H Stock Overview
Many Bright Ideas Technologies Inc. does not have significant operations.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Many Bright Ideas Technologies Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.08 |
52 Week High | CA$0.15 |
52 Week Low | CA$0.005 |
Beta | 0.50 |
1 Month Change | -15.79% |
3 Month Change | 433.33% |
1 Year Change | n/a |
3 Year Change | -30.43% |
5 Year Change | 100.00% |
Change since IPO | -98.00% |
Recent News & Updates
Shareholder Returns
MBI.H | CA Biotechs | CA Market | |
---|---|---|---|
7D | 0% | -3.3% | -0.2% |
1Y | n/a | -39.1% | 6.1% |
Return vs Industry: Insufficient data to determine how MBI.H performed against the Canadian Biotechs industry.
Return vs Market: Insufficient data to determine how MBI.H performed against the Canadian Market.
Price Volatility
MBI.H volatility | |
---|---|
MBI.H Average Weekly Movement | n/a |
Biotechs Industry Average Movement | 11.6% |
Market Average Movement | 8.8% |
10% most volatile stocks in CA Market | 18.2% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: MBI.H's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine MBI.H's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | n/a | Iain Weir-Jones | www.medbiogene.com |
Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was engaged in the life science business with a focus on the development and commercialization of genomic-based tests for non-small-cell lung cancer. It focuses on the commercialization of technologies in various industrial sectors.
Many Bright Ideas Technologies Inc. Fundamentals Summary
MBI.H fundamental statistics | |
---|---|
Market cap | CA$1.38m |
Earnings (TTM) | -CA$79.50k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-17.4x
P/E RatioIs MBI.H overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MBI.H income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$58.11k |
Earnings | -US$58.11k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0034 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0% |
How did MBI.H perform over the long term?
See historical performance and comparison